| Sepsis: definition, epidemiology, and diagnosis A Lever, I Mackenzie Bmj 335 (7625), 879-883, 2007 | 788 | 2007 |
| HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ... Nature 568 (7751), 244-248, 2019 | 676 | 2019 |
| Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions A Lever, H Gottlinger, W Haseltine, J Sodroski Journal of virology 63 (9), 4085-4087, 1989 | 539 | 1989 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 434 | 2021 |
| The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure GP Harrison, AM Lever Journal of virology 66 (7), 4144-4153, 1992 | 314 | 1992 |
| HIV Gag polyprotein: processing and early viral particle assembly NM Bell, AML Lever Trends in microbiology 21 (3), 136-144, 2013 | 285 | 2013 |
| Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin AML Lever, D Brown, ADB Webster, HC Thomas The Lancet 324 (8411), 1062-1064, 1984 | 275 | 1984 |
| Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. SC Knight, J Farrant, A Bryant, AJ Edwards, S Burman, A Lever, J Clarke, ... Immunology 57 (4), 595, 1986 | 255 | 1986 |
| Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector M Poznansky, A Lever, L Bergeron, W Haseltine, J Sodroski Journal of virology 65 (1), 532-536, 1991 | 254 | 1991 |
| Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70 SA Kemp, B Meng, IA Ferriera, R Datir, WT Harvey, G Papa, S Lytras, ... BioRxiv, 2020.12. 14.422555, 2020 | 249 | 2020 |
| Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and … W Cheung, M Gill, A Esposito, CF Kaminski, N Courousse, S Chwetzoff, ... Journal of virology 84 (13), 6782-6798, 2010 | 231 | 2010 |
| Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins DH Gabuzda, A Lever, E Terwilliger, J Sodroski Journal of virology 66 (6), 3306-3315, 1992 | 226 | 1992 |
| Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life T Ikeda, AML Lever, HC Thomas Hepatology 6 (5), 962-965, 1986 | 170 | 1986 |
| HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection M Pignatelli, J Waters, D Brown, A Lever, S Iwarson, Z Schaff, R Gerety, ... Hepatology 6 (3), 349-353, 1986 | 168 | 1986 |
| Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation JF Kaye, AML Lever Journal of virology 72 (7), 5877-5885, 1998 | 159 | 1998 |
| Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy BJ Thomson, AML Lever, M Doran, ADB Webster The Lancet 329 (8532), 539-541, 1987 | 152 | 1987 |
| Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5'leader region JH Richardson, LA Child, AM Lever Journal of virology 67 (7), 3997-4005, 1993 | 148 | 1993 |
| Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line GP Harrison, G Miele, E Hunter, AML Lever Journal of virology 72 (7), 5886-5896, 1998 | 142 | 1998 |
| HIV‐1 Gag–RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET E Poole, P Strappe, HP Mok, R Hicks, AML Lever Traffic 6 (9), 741-755, 2005 | 141 | 2005 |
| Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation JF Kaye, AML Lever Journal of virology 73 (4), 3023-3031, 1999 | 138 | 1999 |
